Comparing Lifezone Metals (NYSE:LZM) and Lexaria Bioscience (OTCMKTS:LXRP)

Lexaria Bioscience (OTCMKTS:LXRPGet Free Report) and Lifezone Metals (NYSE:LZMGet Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Lexaria Bioscience and Lifezone Metals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lexaria Bioscience 0 0 0 0 0.00
Lifezone Metals 0 0 1 0 3.00

Lifezone Metals has a consensus price target of $14.00, suggesting a potential upside of 342.34%. Given Lifezone Metals’ stronger consensus rating and higher probable upside, analysts clearly believe Lifezone Metals is more favorable than Lexaria Bioscience.

Profitability

This table compares Lexaria Bioscience and Lifezone Metals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Lexaria Bioscience -1,046.77% -157.62% -148.09%
Lifezone Metals -24,521.17% -294.91% -237.25%

Institutional & Insider Ownership

0.1% of Lexaria Bioscience shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Lexaria Bioscience and Lifezone Metals”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Lexaria Bioscience $380,000.00 0.00 -$4.09 million N/A N/A
Lifezone Metals $140,522.00 1,762.89 -$363.88 million N/A N/A

Lexaria Bioscience has higher revenue and earnings than Lifezone Metals.

Summary

Lexaria Bioscience beats Lifezone Metals on 6 of the 9 factors compared between the two stocks.

About Lexaria Bioscience

(Get Free Report)

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

About Lifezone Metals

(Get Free Report)

Lifezone Metals Limited engages in the extraction and refining of metals. It supplies lower-carbon and sulfur dioxide emission metals to the battery storage, EV, and hydrogen markets. The company’s products include nickel, copper, and cobalt. Its flagship project is the Kabanga nickel project in North-West Tanzania. The company is based in Ramsey, Isle of Man.

Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.